Medifast INC Form 4 insider transactions

Director Jeffrey Matthew Rose acquired 18,419 shares of Medifast, Inc. common stock through a director compensation plan.

Director Parsa Kiai acquired 19,317 shares of Medifast, Inc. common stock as part of his annual director compensation package.

Director Andrea B. Thomas acquired 11,680 restricted stock units as part of her annual director fee compensation.

Director Scott Schlackman acquired 11,680 restricted stock units as part of his annual director fee compensation.

Medifast, Inc. director Elizabeth A. Geary was granted 11,680 restricted stock units as part of the company's director compensation plan.

Director Xian Ming was granted 11,680 cash-settled restricted stock units as part of an annual incentive plan.

Director Scott Schlackman purchased 5,000 shares of Medifast Inc. common stock across two transactions in May 2026.

Jonathan Barrett MacKenzie, Medifast's VP of Finance & CAO, reported the acquisition of restricted stock units and the disposition of shares for tax obligations.

Medifast's CFO, James P. Maloney, reported a series of stock transactions including restricted stock unit grants, performance stock unit vesting, and shares withheld for tax obligations.

Medifast's Chairman and CEO, Daniel R. Chard, reported a net increase in his beneficial ownership through equity grants and open market purchases.

MEDIFAST, Inc. Director Xian Ming acquired a total of 17,181 restricted stock units as part of annual director fees and compensation, with vesting scheduled for June 25, 2026.

Medifast Inc. Director Scott Schlackman was granted 11,168 restricted stock units as part of his annual director fees, vesting fully on June 25, 2026.

Medifast, Inc. Director Andrea Thomas was granted 11,168 restricted stock units as part of her annual director fees, vesting on June 25, 2026.

Medifast, Inc. Director Michael A. Hoer has reported the acquisition of 11,168 restricted stock units as part of his annual director compensation, vesting in June 2026.

Medifast, Inc. Director Elizabeth A. Geary was granted 11,168 restricted stock units as part of her annual director fees, aligning her interests with shareholders.

Medifast, Inc. Director Jeffrey J. Brown acquired over 20,000 shares of common stock on June 25, 2025, through restricted stock unit grants and an election to receive shares in lieu of cash compensation.

MEDIFAST, Inc. Chairman and CEO Daniel R. Chard reported the acquisition of 381 shares of common stock at $13.13 per share through an irrevocable family trust, increasing his indirect beneficial ownership.

James P. Maloney, CFO of Medifast, Inc., reports the acquisition of 24,161 shares of common stock through a restricted stock unit grant.

Jonathan Barrett MacKenzie, VP, Finance & CAO of Medifast, Inc., reports the acquisition of 7,671 shares of common stock and the disposal of 11,138 shares.

Daniel Chard, Chairman & CEO of Medifast, Inc., reports the acquisition of restricted stock units.

Jonathan MacKenzie, VP of Finance & CAO at Medifast, reported the disposal of common stock to cover withholding tax obligations related to vesting restricted stock units.

James P. Maloney, CFO of Medifast, Inc., reported the disposal of common stock to cover withholding tax obligations related to the vesting of restricted stock units.

Daniel Chard, CEO of Medifast, reported the disposal of shares to cover withholding tax obligations related to the vesting of restricted stock units.

Jonathan Barrett MacKenzie, VP of Finance & CAO at Medifast, Inc., reports the withholding of 11 common stock shares to cover tax obligations related to vesting restricted stock units.

Director Jeffrey Brown reports acquisition of Medifast stock through restricted stock units and election to receive shares in lieu of cash compensation.

Director Andrea B. Thomas received 6,596 restricted stock units from Medifast as part of the Director's Deferred Compensation Plan.

Director Elizabeth A. Geary reports acquisition of restricted stock units and disposal of common stock.

Director Michael A. Hoer reports acquisition of Medifast stock units through a director's deferred compensation plan.

Director Scott Schlackman reports acquisition of restricted stock units and disposal of common stock related to director fees.

Director Xian Ming acquired 10,149 restricted stock units of Medifast, Inc. related to director fees, vesting on June 20, 2025.